Neumora Therapeutics, Inc. (NMRA) dividend history

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.43−0.04 (-8.46%)

Close on Nov 12, 2026Market cap $81.36MP/E –Yield –

Dividends

No dividend per share appears in Neumora Therapeutics's annual filings since fiscal 2021.

See a number that looks wrong?